Skip to main
STAA
STAA logo

STAAR Surgical (STAA) Stock Forecast & Price Target

STAAR Surgical (STAA) Analyst Ratings

Based on 7 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

Staar Surgical Co is a focused manufacturer specializing in implantable lenses and delivery systems for ocular surgeries, with a significant concentration on its ophthalmic surgical product segment. Despite facing competition from larger companies with more substantial financial resources, Staar retains a competitive edge due to its innovative product offerings, particularly in the growing market for refractive surgery and cataract treatment. The company's emphasis on developing high-quality, specialized ophthalmic solutions positions it well for potential revenue growth, driven by increased surgical demand and advancement in eye care technologies.

Bears say

Staar Surgical Co faces potential challenges that could adversely affect its financial performance, primarily due to pressures from larger manufacturers who might engage in price competition, consequently impacting the company's gross margins. Additionally, there is a risk of declining reimbursements for intraocular lenses (IOLs) as governments address healthcare costs related to the aging population, which may hinder revenue from a crucial product line. Furthermore, the company's growth prospects could be jeopardized if it fails to secure regulatory approval for its product pipeline, thereby limiting the expansion of its implantable Collamer lens (ICL) utilization.

STAAR Surgical (STAA) has been analyzed by 7 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About STAAR Surgical (STAA) Forecast

Analysts have given STAAR Surgical (STAA) a Hold based on their latest research and market trends.

According to 7 analysts, STAAR Surgical (STAA) has a Hold consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

STAAR Surgical (STAA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.